Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Tokiwa-Bio

Tokiwa-Bio
2014 FOUNDED
M&A STATUS
M&A LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Developer of a transgenic technology designed to explore the practical application of therapeutic drugs. The company's transgenic technology uses artificially synthesized vectors to introduce multiple genes to cytoplasm without damaging genes in the cell, enabling companies to develop gene therapy drugs for rare diseases such as hemophilia and ischaemic.

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Primary Industry
Other Healthcare Technology Systems
Parent Company
FujiFilm
Primary Office
  • G-4 Tsukuba-TCI 2-1-6 Sengen
  • Tsukuba, 305-0047
  • Japan

+81 000-000-0000

Tokiwa-Bio Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Tokiwa-Bio‘s full profile, request access.

Request full access to PitchBook

Tokiwa-Bio Executive Team (1)

Name Title Board
Seat
Contact
Info
Masaharu Matsuzaki President & Chief Executive Officer